EUVIMEDEUVIMED entdecken
Leitlinie

BrEast cancer in the VEry eldeRLY (BEVERLY-1): Patient characteristics, co-morbidities, drug intake and guideline adherence

N. Jost, F. Fick, D. M. Matlac, K. Milewski, N. Tauber, J. Banys-Kotomska, N. Krawczyk, A. Rody, F. Hemptenmacher, L. Hanker, M. Banys-Paluchowski

Senologie - Zeitschrift für Mammadiagnostik und -therapie · 01.06.2024 · 21 (02) · e15

DOI: 10.1055/s-0044-1786099 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Senologie - Zeitschrift für Mammadiagnostik und -therapie, erschienen am 01.06.2024. Verfasst von N. Jost und 10 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer is the most common cancer in women worldwide. In Germany, the median age at diagnosis is 63 years. Older patients are significantly underrepresented in clinical trials. The present study aimed at analyzing patient and disease characteristics as well as course of treatment in a large group of elderly patients with newly diagnosed breast cancer. Material/Methods: The study is based on a retrospective database of patients 80 years and older with a histologically confirmed breast cancer referred to the certified Breast Cancer Centre of the University Hospital Schleswig-Holstein, Campus Lübeck, within the period of 01.01.2011-31.12.2020. Patient files and tumor documentation records were used as the data source.

Results

A total of 327 patients were included in this analysis, 320 (97.9%) women and seven (2.1%) men. Median age was 83 years (range 80-96). 212 (64.8%) were 80-84 years old, 90 (27.5%) 85-89 years old and 25 (7.6%) 90 years and older. Most frequent comorbidities were hypertension (69.1%), obesity (25.7%), diabetes (19.9%), heart failure (8.3%) and osteoporosis (8.3%). 95.6% took at least one prescribed medication and were using an average of 5 (range 0-20) continued medications . Only 32% were treated according to guidelines. Older age (p

Zitieren

APA

Jost, N., Fick, F., Matlac, D. M., Milewski, K., Tauber, N., Banys-Kotomska, J., Krawczyk, N., Rody, A., Hemptenmacher, F., Hanker, L., & Banys-Paluchowski, M. (2024). BrEast cancer in the VEry eldeRLY (BEVERLY-1): Patient characteristics, co-morbidities, drug intake and guideline adherence. Senologie - Zeitschrift für Mammadiagnostik und -therapie, 21(02), e15. https://doi.org/10.1055/s-0044-1786099

Vancouver

Jost N, Fick F, Matlac DM, Milewski K, Tauber N, Banys-Kotomska J, et al. BrEast cancer in the VEry eldeRLY (BEVERLY-1): Patient characteristics, co-morbidities, drug intake and guideline adherence. Senologie - Zeitschrift für Mammadiagnostik und -therapie. 2024;21(02):e15. doi:10.1055/s-0044-1786099

BibTeX
@article{Jost2024,
  author = {Jost, N. and Fick, F. and Matlac, D. M. and Milewski, K. and Tauber, N. and Banys-Kotomska, J. and Krawczyk, N. and Rody, A. and Hemptenmacher, F. and Hanker, L. and Banys-Paluchowski, M.},
  title = {BrEast cancer in the VEry eldeRLY (BEVERLY-1): Patient characteristics, co-morbidities, drug intake and guideline adherence},
  journal = {Senologie - Zeitschrift für Mammadiagnostik und -therapie},
  year = {2024},
  volume = {21},
  number = {02},
  pages = {e15},
  doi = {10.1055/s-0044-1786099}
}
Kostenlos starten →